Related Experiment Videos
Statins downregulate ATP-binding-cassette transporter A1 gene expression in macrophages
Hirohito Sone1, Hitoshi Shimano, Miao Shu
1Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Biochemical and Biophysical Research Communications
|March 23, 2004
Summary
Statins, used to lower cholesterol, were found to suppress ATP-binding-cassette transporter A1 (ABCA1) mRNA expression in macrophages. This suppression, which impacts cholesterol efflux, was reversed by mevalonate, suggesting a modulation of statins' beneficial effects.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- ATP-binding-cassette transporter A1 (ABCA1) is crucial for cellular cholesterol efflux, preventing macrophage foam cell formation.
- Statins are widely prescribed cholesterol-lowering drugs with known anti-atherogenic properties.
Purpose of the Study:
- To investigate the in vitro effects of four different statins on ABCA1 expression in macrophages.
- To determine the impact of statins on the reverse cholesterol transport pathway.
Main Methods:
- Exposure of RAW246.7, THP-1 macrophage cell lines, and mouse peritoneal macrophages to fluvastatin, atorvastatin, simvastatin, and lovastatin.
- Measurement of ABCA1 mRNA expression.
- Assessment of the effect of mevalonate on statin-induced suppression.
Main Results:
- All four tested statins significantly suppressed ABCA1 mRNA expression in all macrophage models.
- The observed suppression was dependent on both time and statin dose.
- Addition of mevalonate abolished the statins' suppressive effect on ABCA1 mRNA expression.
Conclusions:
- Statins can modulate ABCA1 expression in macrophages, potentially affecting cholesterol efflux.
- The findings suggest a complex interaction between statins and the reverse cholesterol transport pathway.
- Further research is warranted to understand the clinical implications of statin-induced ABCA1 suppression.